Correlation Studies on Human Body Composition Based on Bioequivalence or Pharmacokinetic Trials
Recruiting now
Conditions studied: Healhty
In brief
The aim of this observational study is to investigate the impact of body composition on the absorption, distribution, and metabolism of drugs. The primary question it seeks to answer is: Does body composition affect the absorption, distribution, and metabolism of drugs? By combining pharmacokinetic parameters and adverse drug reactions, the study will analyze differences in the metabolism of drugs under various body composition conditions. During the Phase I clinical trial, under the guidance of the researchers, subjects will use the non-invasive InBody S10 body composition analyzer to obtain body composition data, including but not limited to inorganic salts, muscle mass, lean body mass, body weight, and body fat percentage.
Key facts
- Study ID
- NCT07611929
- Run by
- Second Affiliated Hospital of Wenzhou Medical University
- People needed
- 3000
- Starts
- 2024-10-05
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2026-05-28
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants who have been successfully enrolled in the bioequivalence trials of Progesterone Sustained-release vaginal gel；
- Have signed the informed consent form, have a full understanding of the content, process, and risks of this study, and can communicate well with the researchers.
- Exclusion Criteria:1:
- 1）Participants who may not be able to complete the study for other reasons or are deemed by the investigator to be unsuitable for participation in this study.
Where it is running
- The Second Affiliated Hospital and Yuying Children's Hospital Affiliated to Wenzhou Medical University — Wenzhou, Zhejiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.